CSIO yields 0.67% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, CSIO + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CSIO + MRK for your $10,000?
CSIO invests primarily in a concentrated portfolio of US and international infrastructure companies. Security selection is based on a value-oriented, bottom-up research process, evaluating firms on financial strength, management quality, industry positioning, and valuation metrics such as price/earnings, price/cash flow, dividend yield, and earnings growth. Eligible company exposure ranges from utilities, energy transport, communications networks, transportation systems, social infrastructure, and related suppliers, with up to 25% allocated to emerging markets. While CSIOs focus is common stocks, the fund may also hold preferred securities, hybrids, PIPEs, REIT-structured infrastructure assets, IPOs, and up to 20% in fixed-income securities. The fund does not target specific ESG outcomes but considers relevant ESG factors when assessing opportunities. Derivatives and currency hedging may be used mainly for risk management purposes.
Full CSIO Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.